Nuvation Bio (NUVB) Equity Average (2023 - 2025)
Historic Equity Average for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $349.4 million.
- Nuvation Bio's Equity Average fell 804.28% to $349.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $349.4 million, marking a year-over-year decrease of 804.28%. This contributed to the annual value of $534.5 million for FY2024, which is N/A changed from last year.
- Latest data reveals that Nuvation Bio reported Equity Average of $349.4 million as of Q3 2025, which was down 804.28% from $396.2 million recorded in Q2 2025.
- Nuvation Bio's Equity Average's 5-year high stood at $632.9 million during Q2 2023, with a 5-year trough of $349.4 million in Q3 2025.
- Its 3-year average for Equity Average is $493.5 million, with a median of $462.4 million in 2024.
- Per our database at Business Quant, Nuvation Bio's Equity Average tumbled by 3852.98% in 2024 and then crashed by 691.56% in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Equity Average stood at $608.4 million in 2023, then fell by 20.56% to $483.3 million in 2024, then decreased by 27.7% to $349.4 million in 2025.
- Its Equity Average was $349.4 million in Q3 2025, compared to $396.2 million in Q2 2025 and $441.6 million in Q1 2025.